4.6 Article

Epigenetic Regulation of Cancer Stem Cells by the Aryl Hydrocarbon Receptor Pathway

期刊

SEMINARS IN CANCER BIOLOGY
卷 83, 期 -, 页码 177-196

出版社

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.semcancer.2020.08.014

关键词

Cancer stem cells; Aryl hydrocarbon receptor; Epigenesis; Histone modification; DNA methylation; MicroRNAs; Chemoresistance

类别

资金

  1. Office of Research Support at Qatar University [IRCC-2019-006, QUCG-CPH-20/21-1, QUST-1-CPH-2020-6]
  2. Qatar Foundation - Qatar National Research Fund [UREP24-163-3-049]
  3. Qatar National Library

向作者/读者索取更多资源

This article summarizes the characteristics and important roles of cancer stem cells (CSCs) and their connection with environmental toxin PAHs and cytosolic receptor AhR. The review also discusses the signaling pathways related to tumorigenesis and progression that are mediated by AhR, as well as the epigenetic regulations of CSCs by the AhR/CYP1A pathway.
Compelling evidence has demonstrated that tumor bulk comprises distinctive subset of cells generally referred as cancer stem cells (CSCs) that have been proposed as a strong sustainer and promoter of tumorigenesis and therapeutic resistance. These distinguished properties of CSCs have raised interest in understanding the mo-lecular mechanisms that govern the maintenance of these cells. Numerous experimental and epidemiological studies have demonstrated that exposure to environmental toxins such as the polycyclic aromatic hydrocarbons (PAHs) is strongly involved in cancer initiation and progression. The PAH-induced carcinogenesis is shown to be mediated through the activation of a cytosolic receptor, aryl hydrocarbon receptor (AhR)/Cytochrome P4501A pathway, suggesting a possible direct link between AhR and CSCs. Several recent studies have investigated the role of AhR in CSCs self-renewal and maintenance, however the molecular mechanisms and particularly the epigenetic regulations of CSCs by the AhR/CYP1A pathway have not been reviewed before. In this review, we first summarize the crosstalk between AhR and cancer genetics, with a particular emphasis on the mechanisms relevant to CSCs such as Wnt/beta-catenin, Notch, NF-kappa B, and PTEN-PI3K/Akt signaling pathways. The second part of this review discusses the recent advances and studies highlighting the epigenetic mechanisms mediated by the AhR/CYP1A pathway that control CSC gene expression, self-renewal, and chemoresistance in various human cancers. Furthermore, the review also sheds light on the importance of targeting the epigenetic pathways as a novel therapeutic approach against CSCs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据